This article was reviewed and updated on 28 August, 2025 by Dr
See recent WSJ article here Enthusiasts (biohackers?) and some longevity-focused clinicians believe that microdosing these drugs offers benefits beyond weight loss, such as improved metabolic health, glycemic control, reduced systemic inflammation, and potentially even a lower risk of age-related diseases
These questions help patients avoid the biggest mistake: starting a peptide protocol without a monitoring plan
Causing fat loss while maintaining muscle mass would therefore be an attractive feature of a novel therapeutic (Versanis bimagrumab may be differentiated here)
In new clinical trial results from the pharmaceutical company Eli Lilly, a weekly injection of 12 milligrams (0.19 grain) of retatrutide for 80 weeks helped people lose almost 30 percent of their body weightabout 70 pounds on averageaccording to a statement from the company
Depress the syringe plunger slowly, allowing the bacteriostatic water to run down the inside wall of the vial and pool at the bottom, gradually hydrating the peptide powder through diffusion rather than direct impact